Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells - PubMed (original) (raw)
Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells
P M Challita et al. J Virol. 1995 Feb.
Abstract
Infection by murine retroviruses in embryonic carcinoma (EC) and embryonic stem cells is highly restricted. The transcriptional unit of the Moloney murine leukemic virus (MoMuLV) long terminal repeat (LTR) is inactive in EC and embryonic stem cells in association with increased proviral methylation. In this study, expression in F9 EC cells was achieved from novel retroviral vectors containing three modifications in the MoMuLV-based retroviral vector: presence of the myeloproliferative sarcoma virus LTR, substitution of the primer binding site, and either deletion of a negative control region at the 5' end of the LTR or insertion of a demethylating sequence. We conclude that inhibition of expression from the MoMuLV LTR in EC cells is mediated through the additive effects of multiple cis-acting elements affecting the state of methylation of the provirus.
Similar articles
- Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
Feuer G, Taketo M, Hanecak RC, Fan H. Feuer G, et al. J Virol. 1989 May;63(5):2317-24. doi: 10.1128/JVI.63.5.2317-2324.1989. J Virol. 1989. PMID: 2704078 Free PMC article. - High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors.
Wang L, Robbins PB, Carbonaro DA, Kohn DB. Wang L, et al. Hum Gene Ther. 1998 Nov 1;9(16):2321-30. doi: 10.1089/hum.1998.9.16-2321. Hum Gene Ther. 1998. PMID: 9829531 - Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.
Robbins PB, Skelton DC, Yu XJ, Halene S, Leonard EH, Kohn DB. Robbins PB, et al. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10182-7. doi: 10.1073/pnas.95.17.10182. Proc Natl Acad Sci U S A. 1998. PMID: 9707621 Free PMC article. - Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.
Challita PM, Kohn DB. Challita PM, et al. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2567-71. doi: 10.1073/pnas.91.7.2567. Proc Natl Acad Sci U S A. 1994. PMID: 8146155 Free PMC article. - Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.
Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W. Baum C, et al. J Hematother. 1996 Aug;5(4):323-9. doi: 10.1089/scd.1.1996.5.323. J Hematother. 1996. PMID: 8877707 Review.
Cited by
- Gene therapy for the hemoglobin disorders: past, present, and future.
Persons DA, Nienhuis AW. Persons DA, et al. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5022-4. doi: 10.1073/pnas.97.10.5022. Proc Natl Acad Sci U S A. 2000. PMID: 10805762 Free PMC article. Review. No abstract available. - Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by UNC13D Genetic Defects.
Takushi SE, Paik NY, Fedanov A, Prince C, Doering CB, Spencer HT, Chandrakasan S. Takushi SE, et al. Hum Gene Ther. 2020 Jun;31(11-12):626-638. doi: 10.1089/hum.2019.329. Hum Gene Ther. 2020. PMID: 32253931 Free PMC article. - Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.
Robbins PB, Yu XJ, Skelton DM, Pepper KA, Wasserman RM, Zhu L, Kohn DB. Robbins PB, et al. J Virol. 1997 Dec;71(12):9466-74. doi: 10.1128/JVI.71.12.9466-9474.1997. J Virol. 1997. PMID: 9371608 Free PMC article. - Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer.
Lund AH, Duch M, Lovmand J, Jørgensen P, Pedersen FS. Lund AH, et al. J Virol. 1997 Feb;71(2):1191-5. doi: 10.1128/JVI.71.2.1191-1195.1997. J Virol. 1997. PMID: 8995641 Free PMC article. - Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector.
Singh S, Khan I, Khim S, Seymour B, Sommer K, Wielgosz M, Norgaard Z, Kiem HP, Adair J, Liggitt D, Nienhuis A, Rawlings DJ. Singh S, et al. Mol Ther Methods Clin Dev. 2016 Dec 18;4:1-16. doi: 10.1016/j.omtm.2016.11.001. eCollection 2017 Mar 17. Mol Ther Methods Clin Dev. 2016. PMID: 28344987 Free PMC article.
References
- Cell. 1985 Sep;42(2):519-26 - PubMed
- Proc Natl Acad Sci U S A. 1985 Sep;82(17):5746-50 - PubMed
- J Virol. 1986 Jan;57(1):37-45 - PubMed
- Virology. 1986 Aug;153(1):145-9 - PubMed
- Mol Cell Biol. 1986 Jan;6(1):286-93 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous